Search
Browse
- Diseases
- Sponsors
Pipeline Pulse
Watchlist
Blog
Pricing

Sign in

Sponsor pipeline

Processa Pharmaceuticals

Filter by disease

Loading trials...

1 trial changed in the last 30 days: 1 stopped, 0 with notable changes, 0 with minor changes only.

ImportanceWhat changedUpdated

Stopped

PCS6422 With Capecitabine · Advanced or Metastatic Breast Cancer

Trial terminated

Also in this update: Final enrollment: 20 participants (planned 90); Primary completion date changed from estimate of Sep 2026 to Jul 29, 2026

Processa PharmaceuticalsPhase 2 NCT06568692 Registry history of NCT06568692 on ClinicalTrials.gov (opens the registry)

Oct 6, 2026

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Loading therapeutic areas...

Data updated daily from ClinicalTrials.gov.

0 trials selected Compare →

Sign in to save sponsors

Enter your email to receive a login link. No password needed.

Check your email for a login link.

datalookout.com Blog Privacy Terms Cookie settings

© 2026 DataLookout. Data from ClinicalTrials.gov. Not affiliated with the NLM.